Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Here's Why Novavax (NVAX) Fell More Than Broader Market
06:45pm, Wednesday, 28'th Jan 2026
In the latest trading session, Novavax (NVAX) closed at $9.22, marking a -6.07% move from the previous day.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:10am, Monday, 26'th Jan 2026
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Novavax (NVAX) Stock Dips While Market Gains: Key Facts
06:45pm, Thursday, 22'nd Jan 2026
In the latest trading session, Novavax (NVAX) closed at $9.71, marking a -1.97% move from the previous day.
Novavax Grants License for Use of Matrix-M Adjuvant to Pfizer
11:11am, Wednesday, 21'st Jan 2026
NVAX inks a non-exclusive Matrix-M license, securing $30M upfront, up to $500M in milestones and mid-single-digit royalties from Pfizer.
Novavax Stock Pops After Pfizer Licensing Agreement
11:12am, Tuesday, 20'th Jan 2026
Novavax Inc. (NASDAQ:NVAX) shares are up 3.3% to trade at $8.27 at last glance, after the vaccine company singed a licensing agreement -- worth up to $500 million, including a $30 million upfront p
Novavax Announces Entering into a License Agreement with Pfizer
07:15am, Tuesday, 20'th Jan 2026
Non-exclusive license allows for development by Pfizer to utilize Matrix-M ® for up to two disease areas with its products Provides Novavax with an upfront payment of $30 million with the potential f
Novavax enters license agreement with Pfizer for vaccine development
07:11am, Tuesday, 20'th Jan 2026
Novavax said on Tuesday it was entering into a licensing agreement with Pfizer to develop vaccine products for infectious diseases.
Novavax, Inc. (NVAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
10:15pm, Wednesday, 14'th Jan 2026
Novavax, Inc. (NVAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Why Novavax (NVAX) Dipped More Than Broader Market Today
06:46pm, Wednesday, 14'th Jan 2026
Novavax (NVAX) concluded the recent trading session at $8.19, signifying a -5.54% move from its prior day's close.
Novavax (NVAX) Moves 11.9% Higher: Will This Strength Last?
09:21am, Wednesday, 14'th Jan 2026
Novavax (NVAX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 13'th Jan 2026
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference
08:00am, Wednesday, 07'th Jan 2026
GAITHERSBURG, Md., Jan. 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44th Annual J.P.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Tuesday, 30'th Dec 2025
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
10:01am, Friday, 19'th Dec 2025
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why I Wouldn't Touch Novavax With a 10-Foot Pole
12:41pm, Thursday, 11'th Dec 2025
Novavax faces plenty of uncertainty related to a deal it signed with a larger company. The biotech's pipeline doesn't look that exciting either.
